14. Urges all Member States experiencing resistance to conventional monotherapies to replace them with combination therapies, as recommended by the World Health Organization, and to develop the necessary financial, legislative and regulatory mechanisms in order to introduce artemisinin combination therapies at affordable prices and to prohibit the marketing of oral artemisinin monotherapies, in a timely manner;
14. 敦促所有发现对常规单一疗法产生抗药性病例的会员国及时改用世界卫生组织建议采用的复方疗法，建立必要的财政、立法和监管机制，以便及时以负担得起的价格推行青蒿素复方疗法，禁止推销各种口服青蒿素单一疗法；